Tsukagoshi H and Kurosawa M |
[Bronchial hyperresponsiveness to histamine induced by intravenous administration of prostaglandin D2 (PGD2) in guinea pigs]. |
1992 |
Nippon Yakurigaku Zasshi |
pmid:1559641
|
Hwang J et al. |
Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. |
2005 |
Am. J. Physiol., Cell Physiol. |
pmid:15590897
|
Almishri W et al. |
Effects of prostaglandin D2, 15-deoxy-Delta12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15590767
|
Kim YS et al. |
Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity. |
2005 |
Free Radic. Biol. Med. |
pmid:15589375
|
Mitsumori S |
Recent progress in work on PGD2 antagonists for drugs targeting allergic diseases. |
2004 |
Curr. Pharm. Des. |
pmid:15579050
|
Hata AN et al. |
Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2. |
2005 |
Mol. Pharmacol. |
pmid:15563582
|
Józkowicz A et al. |
15-deoxy-delta12,14-prostaglandin-J2 inhibits expression of eNOS in human endothelial cells. |
2004 |
Prostaglandins Other Lipid Mediat. |
pmid:15560113
|
Kim BE et al. |
Involvement of Sox-4 in the cytochrome c-dependent AIF-independent apoptotic pathway in HeLa cells induced by Delta12-prostaglandin J2. |
2004 |
Exp. Mol. Med. |
pmid:15557816
|
Chen Q et al. |
A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist. |
2004 |
Anal. Biochem. |
pmid:15556564
|
Arai I et al. |
Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. |
2004 |
Eur. J. Pharmacol. |
pmid:15556157
|
Chen F |
Endogenous inhibitors of nuclear factor-kappaB, an opportunity for cancer control. |
2004 |
Cancer Res. |
pmid:15548674
|
Abdelrahman M et al. |
The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock. |
2004 |
Shock |
pmid:15545828
|
Subbarayan V et al. |
Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells. |
2004 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:15533897
|
Sabichi AL et al. |
Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells. |
2004 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:15533896
|
Nie M et al. |
Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists. |
2005 |
J. Biol. Chem. |
pmid:15531761
|
Shiraishi Y et al. |
Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15528449
|
Li Z et al. |
Neurotoxic prostaglandin J2 enhances cyclooxygenase-2 expression in neuronal cells through the p38MAPK pathway: a death wish? |
2004 |
J. Neurosci. Res. |
pmid:15523637
|
Yoshida M et al. |
Methotrexate enhances prostaglandin D2-stimulated heat shock protein 27 induction in osteoblasts. |
2004 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:15519494
|
Eucker J et al. |
Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma. |
2004 |
Anticancer Drugs |
pmid:15514564
|
Shimakura S and Boland CR |
Eicosanoid production by the human gastric cancer cell line AGS and its relation to cell growth. |
1992 |
Cancer Res. |
pmid:1551103
|
Huang H et al. |
Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510. |
2004 |
Mol. Cancer Res. |
pmid:15498928
|
Piva R et al. |
15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins. |
2005 |
Blood |
pmid:15498850
|
Chen HH et al. |
Effects of trichloroethylene and perchloroethylene on muscle contractile responses and epithelial prostaglandin release and acetylcholinesterase activity in swine trachea. |
2005 |
Toxicol. Sci. |
pmid:15496499
|
Emmans VC et al. |
Regulation of cellular processes by PPARgamma ligands in neuroblastoma cells is modulated by the level of retinoblastoma protein expression. |
2004 |
Biochem. Soc. Trans. |
pmid:15494029
|
Hayaishi O et al. |
Genes for prostaglandin d synthase and receptor as well as adenosine A2A receptor are involved in the homeostatic regulation of nrem sleep. |
2004 |
Arch Ital Biol |
pmid:15493554
|
Ishii T and Uchida K |
Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2. |
2004 |
Chem. Res. Toxicol. |
pmid:15487891
|
Konopleva M et al. |
Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. |
2004 |
Mol. Cancer Ther. |
pmid:15486192
|
Giri S et al. |
The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. |
2004 |
J. Immunol. |
pmid:15470065
|
Tsuji T et al. |
Differential effects of beta2-adrenoceptor desensitization on the IgE-dependent release of chemical mediators from cultured human mast cells. |
2004 |
Biol. Pharm. Bull. |
pmid:15467193
|
Ray DM et al. |
Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligands. |
2004 |
Clin. Immunol. |
pmid:15451478
|
Lappas M et al. |
Effect of nuclear factor-kappa B inhibitors and peroxisome proliferator-activated receptor-gamma ligands on PTHrP release from human fetal membranes. |
2004 Sep-Oct |
Placenta |
pmid:15450387
|
Lee DY et al. |
Prostaglandin profile and synthetic capacity of the colon: comparison of tissue sources and subcellular fractions. |
1992 |
Prostaglandins |
pmid:1542741
|
Koizumi T et al. |
Induction of heme oxygenase by delta 12-prostaglandin J2 in porcine aortic endothelial cells. |
1992 |
Prostaglandins |
pmid:1542739
|
Monneret G et al. |
Effects of prostaglandin D(2) and 5-lipoxygenase products on the expression of CD203c and CD11b by basophils. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15388786
|
Morii E and Oboki K |
MITF is necessary for generation of prostaglandin D2 in mouse mast cells. |
2004 |
J. Biol. Chem. |
pmid:15375155
|
Ichiki T et al. |
15-Deoxy-Delta12,14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15369766
|
Dugo L et al. |
15d-prostaglandin J2 reduces multiple organ failure caused by wall-fragment of Gram-positive and Gram-negative bacteria. |
2004 |
Eur. J. Pharmacol. |
pmid:15364008
|
Yuan ZY et al. |
PPAR-gamma ligands inhibit the expression of inflammatory cytokines and attenuate autoimmune myocarditis. |
2004 |
Chin. Med. J. |
pmid:15361304
|
Ehara N et al. |
Activators of PPARgamma antagonize protection of cardiac myocytes by endothelin-1. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15358182
|
Magnussen H et al. |
Effects of a thromboxane-receptor antagonist, BAY u 3405, on prostaglandin D2- and exercise-induced bronchoconstriction. |
1992 |
J. Allergy Clin. Immunol. |
pmid:1535083
|
Atkins KB et al. |
Effects of PPAR-gamma ligands on vascular smooth muscle marker expression in hypertensive and normal arteries. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15345487
|
Luster AD and Tager AM |
T-cell trafficking in asthma: lipid mediators grease the way. |
2004 |
Nat. Rev. Immunol. |
pmid:15343370
|
Hirata Y et al. |
Anti-apoptotic and pro-apoptotic effect of NEPP11 on manganese-induced apoptosis and JNK pathway activation in PC12 cells. |
2004 |
Brain Res. |
pmid:15342272
|
Li L et al. |
Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblasts. |
2004 |
J. Hepatol. |
pmid:15336443
|
Cheng J et al. |
Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15325252
|
Si Q et al. |
15-deoxy-Delta12,14-prostaglandin J2 inhibits IFN-inducible protein 10/CXC chemokine ligand 10 expression in human microglia: mechanisms and implications. |
2004 |
J. Immunol. |
pmid:15322215
|
Schlezinger JJ et al. |
Environmental and endogenous peroxisome proliferator-activated receptor gamma agonists induce bone marrow B cell growth arrest and apoptosis: interactions between mono(2-ethylhexyl)phthalate, 9-cis-retinoic acid, and 15-deoxy-Delta12,14-prostaglandin J2. |
2004 |
J. Immunol. |
pmid:15322177
|
Sasaguri T and Miwa Y |
Prostaglandin J2 family and the cardiovascular system. |
2004 |
Curr Vasc Pharmacol |
pmid:15320511
|
Lim SY et al. |
15-Deoxy-Delta12,14-prostaglandin J(2) protects against nitrosative PC12 cell death through up-regulation of intracellular glutathione synthesis. |
2004 |
J. Biol. Chem. |
pmid:15319433
|
Shahab R et al. |
Prostaglandins, leukotrienes and perennial rhinitis. |
2004 |
J Laryngol Otol |
pmid:15318955
|
Sinzinger H et al. |
Isradipine improves platelet function in hypertensives. |
1992 |
Eur. J. Clin. Pharmacol. |
pmid:1531796
|
Sánchez-Gómez FJ et al. |
Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. |
2004 |
Mol. Pharmacol. |
pmid:15317873
|
Siavash H et al. |
Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ(2) in oral squamous carcinoma cells. |
2004 |
Br. J. Cancer |
pmid:15316561
|
Szczeklik W et al. |
Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. |
2004 |
J. Allergy Clin. Immunol. |
pmid:15316498
|
Weber SM et al. |
PPARgamma ligands induce ER stress in pancreatic beta-cells: ER stress activation results in attenuation of cytokine signaling. |
2004 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:15315910
|
Kielian T et al. |
S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2). |
2004 |
J. Neurochem. |
pmid:15312171
|
Boyault S et al. |
15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway. |
2004 |
FEBS Lett. |
pmid:15304320
|
Servidei T et al. |
The cellular response to PPARgamma ligands is related to the phenotype of neuroblastoma cell lines. |
2004 |
Oncol. Res. |
pmid:15301425
|
Yoshimura-Uchiyama C et al. |
Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. |
2004 |
Clin. Exp. Allergy |
pmid:15298571
|
Grau R et al. |
Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. |
2004 |
Cancer Res. |
pmid:15289320
|
Eguchi N et al. |
Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats. |
1992 |
J. Pharmacol. Exp. Ther. |
pmid:1527717
|
Hofnagel O et al. |
Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells. |
2004 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15271788
|
Zhang X et al. |
Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells. |
2004 |
Blood |
pmid:15265789
|
Zhao ML et al. |
15-deoxy-delta (12,14)-PGJ2 inhibits astrocyte IL-1 signaling: inhibition of NF-kappaB and MAP kinase pathways and suppression of cytokine and chemokine expression. |
2004 |
J. Neuroimmunol. |
pmid:15265671
|
Jawerbaum A et al. |
Influence of peroxisome proliferator-activated receptor gamma activation by its endogenous ligand 15-deoxy Delta12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women. |
2004 |
Mol. Hum. Reprod. |
pmid:15258247
|
Tanaka Y et al. |
Enhanced release of prostaglandin D2 during re-incubation of RAW 264.7 macrophage-like cells after treatment of both lipopolysaccharide and non-steroidal anti-inflammatory drugs. |
2004 |
Biol. Pharm. Bull. |
pmid:15256727
|
Morosetti R et al. |
The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. |
2004 |
Int. J. Oncol. |
pmid:15254749
|
Berry EB et al. |
Differential effects of serum constituents on apoptosis induced by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in WISH epithelial cells. |
2004 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:15253890
|
Kanunfre CC et al. |
Ciglitizone and 15d PGJ2 induce apoptosis in Jurkat and Raji cells. |
2004 |
Int. Immunopharmacol. |
pmid:15251113
|
Fernández-Tome M et al. |
p44/42(ERK1/2) MAPK and PLD activation by PGD2 preserves papillary phosphatidylcholine homeostasis. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15249196
|
Zhang C et al. |
The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sézary syndrome cells. |
2004 |
J. Invest. Dermatol. |
pmid:15245439
|
Azuma Y et al. |
Induction of proliferation by 15-deoxy-delta12,14-prostaglandin J2 and the precursors in monocytic leukemia U937. |
2004 |
Pharmacology |
pmid:15240994
|
Krueger JM et al. |
Prostaglandins E2 and D2 have little effect on rabbit sleep. |
1992 |
Physiol. Behav. |
pmid:1523224
|
Shan ZZ et al. |
A potential role of 15-deoxy-delta(12,14)-prostaglandin J2 for induction of human articular chondrocyte apoptosis in arthritis. |
2004 |
J. Biol. Chem. |
pmid:15213234
|
Park KS et al. |
Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway. |
2004 |
Exp. Cell Res. |
pmid:15212945
|
Shimomura K et al. |
Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15201343
|
Ruiz PA et al. |
15-deoxy-delta12,14-prostaglandin J2-mediated ERK signaling inhibits gram-negative bacteria-induced RelA phosphorylation and interleukin-6 gene expression in intestinal epithelial cells through modulation of protein phosphatase 2A activity. |
2004 |
J. Biol. Chem. |
pmid:15199053
|
Li Z et al. |
Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15194490
|
Siavash H et al. |
Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells. |
2004 |
Cancer Lett. |
pmid:15194221
|
Cheron A et al. |
15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process. |
2004 |
J. Immunol. |
pmid:15187150
|
Takeshita K et al. |
CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. |
2004 |
Int. Immunol. |
pmid:15173122
|
Son DJ et al. |
Antiplatelet effect of green tea catechins: a possible mechanism through arachidonic acid pathway. |
2004 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:15172681
|
Hawcroft G et al. |
Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells. |
2004 |
Cancer Lett. |
pmid:15172124
|
Rodway HA et al. |
Lysophosphatidic acid attenuates the cytotoxic effects and degree of peroxisome proliferator-activated receptor gamma activation induced by 15-deoxyDelta12,14-prostaglandin J2 in neuroblastoma cells. |
2004 |
Biochem. J. |
pmid:15171682
|
Bochenek G et al. |
Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. |
2004 |
Thorax |
pmid:15170023
|
Dahlén SE and Kumlin M |
Monitoring mast cell activation by prostaglandin D2 in vivo. |
2004 |
Thorax |
pmid:15170020
|
Yuan Z et al. |
Peroxisome proliferator-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis associated with inhibition of self-sensitive T cells. |
2004 |
J. Cardiovasc. Pharmacol. |
pmid:15167281
|
Kaiser L et al. |
Dirofilaria immitis: do filarial cyclooxygenase products depress endothelium-dependent relaxation in the in vitro rat aorta? |
1992 |
Exp. Parasitol. |
pmid:1516664
|
Miwa Y et al. |
Involvement of clusterin in 15-deoxy-delta12,14-prostaglandin J2-induced vascular smooth muscle cell differentiation. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15158456
|
Ward C et al. |
Regulation of granulocyte apoptosis by NF-kappaB. |
2004 |
Biochem. Soc. Trans. |
pmid:15157161
|
Cipollone F et al. |
Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. |
2004 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15155382
|
Park EY et al. |
Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer. |
2004 |
Cancer Res. |
pmid:15150131
|
Garg TK and Chang JY |
15-deoxy-delta 12, 14-Prostaglandin J2 prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stress. |
2004 |
BMC Pharmacol. |
pmid:15149553
|
Chana RS et al. |
Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists. |
2004 |
Kidney Int. |
pmid:15149321
|
Thomas PS et al. |
Prostaglandin D2 production and identification of prostaglandin H synthase within canine mast cell granule. |
1992 |
Am. J. Physiol. |
pmid:1514641
|
Han S et al. |
Ligands of peroxisome proliferator-activated receptor gamma inhibit lung cancer cell growth and induce apoptosis by stimulation of P21 expression. |
2004 |
Chest |
pmid:15136464
|
Akbiyik F et al. |
Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. |
2004 |
Blood |
pmid:15130939
|
Verrier E et al. |
PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase. |
2004 |
Circ. Res. |
pmid:15117825
|
Jakob M et al. |
Chondrogenesis of expanded adult human articular chondrocytes is enhanced by specific prostaglandins. |
2004 |
Rheumatology (Oxford) |
pmid:15113997
|
Zang C et al. |
Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia. |
2004 |
Leuk. Res. |
pmid:15109539
|